Scarica l'app Stockscreener
106.41
1.34%
-1.44
Dopo l'orario di chiusura:
108.31
1.90
+1.79%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
LeMaitre Vascular Hits Day High with 24.41% Surge in Stock Price - Markets Mojo
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo
LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Buy Ratings Amid Steady Revenue Growth - DirectorsTalk Interviews
LeMaitre (LMAT) director Roush gains 476 shares from PSU vesting - Stock Titan
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock By Investing.com - Investing.com India
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com
LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan
LeMaitre Vascular (LMAT) director gains stock through PSU vesting and dividend rights - Stock Titan
LMAT (LMAT) CEO LeMaitre reports 205,930-share sale, PSU vesting and gift - Stock Titan
George W. LeMaitre sells 150,000 shares (LMAT) in Form 144 - Stock Titan
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance
LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance
LeMaitre Vascular Signals Confident Growth in Earnings Call - The Globe and Mail
LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory - Yahoo Finance
LMAT: Morgan Stanley Smith Barney files Form 144 for vested restricted shares (LMAT) - Stock Titan
LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha
LeMaitre to Participate at Upcoming Investor Conferences in March - marketscreener.com
Five investor conferences spotlight LeMaitre in busy March - Stock Titan
[144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play? - TIKR.com
LeMaitre Vascular Q4 2025 Earnings: Revenue & Profit Exceed ExpectationsNews and Statistics - IndexBox
LeMaitre Vascular stock reaches 52-week high at 103.05 USD By Investing.com - Investing.com Australia
LeMaitre Vascular (LMAT) Gets Price Target Boost from Barrington Research | LMAT Stock News - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $105.00 - MarketBeat
LeMaitre Vascular Q4 2025 Earnings Beat, Provides Strong 2026 OutlookNews and Statistics - IndexBox
LeMaitre Sees Growth Surge with Promising Earnings, Revenue Outlook - StocksToTrade
Roth Mkm Reaffirms Buy Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views - Benzinga
LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results - marketscreener.com
LeMaitre (LMAT) Stock Trades Up, Here Is Why - Finviz
LMAT Price Target Raised by Wells Fargo | LMAT Stock News - GuruFocus
Wells Fargo & Company Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LMAT: Citizens Raises Price Target to $118, Maintains Market Out - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings - MarketBeat
Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating - marketscreener.com
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
LeMaitre Vascular stock reaches 52-week high at 103.05 USD - Investing.com
Income Plays: Is LeMaitre Vascular Inc stock a value trapJuly 2025 Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LEMAITRE VASCULAR INC SEC 10-K Report - TradingView
LeMaitre Vascular (LMAT) Reports Strong Q4 2025 Performance and Positive 2026 Outlook - GuruFocus
LeMaitre Vascular Q4 Earnings Call Highlights - MarketBeat
LeMaitre Vascular Inc (LMAT) Q4 2025 Earnings Call Highlights: R - GuruFocus
Earnings call transcript: LeMaitre Vascular beats Q4 2025 expectations - Investing.com Nigeria
Insider Sell: Does LeMaitre Vascular Inc. stock have upside surprise potential - mfd.ru
Discipline and Rules-Based Execution in LMAT Response - Stock Traders Daily
LeMaitre Vascular (NASDAQ:LMAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Earnings call transcript: LeMaitre Vascular beats Q4 2025 expectations By Investing.com - Investing.com India
LeMaitre Vascular Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - Finviz
LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Releases FY 2026 Earnings Guidance - MarketBeat
Q4 2025 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
LeMaitre Vascular, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
LeMaitre Vascular beat Q4 sales expectations, raises dividend - TradingView
(LMAT) LeMaitre Vascular, Inc. Expects Q1 Revenue Range $65.6M$67.6M - marketscreener.com
Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q4 Revenue $64.5M, vs. FactSet Est of $62.8M - marketscreener.com
LeMaitre lifts dividend 25% and okays $100M stock buyback - Stock Titan
LeMaitre Vascular earnings on deck: Can margin gains continue? - Investing.com
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
0.58%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):